Dermatrials Research   Report issue

For profit Phase 4
Founded: Hamilton Canada (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2009
NCT00833729
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

etanercept (enbrel) (2 trials)

tretinoin (Retin-A) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Psoriasis (Phase 4)

Recurrence (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 2